<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01219244</url>
  </required_header>
  <id_info>
    <org_study_id>nutrition_memory_01</org_study_id>
    <nct_id>NCT01219244</nct_id>
  </id_info>
  <brief_title>Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)</brief_title>
  <official_title>Enhancing Memory Functions in Patients With Mild Cognitive Impairment by Dietary Interventions and in Combination With Exercise and Cognitive Training - Proof of Concept and Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate whether dietary modification could provide positive effects on
      brain functions in elderly people with mild cognitive impairment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The age-related degradation of cognitive functions even to the point of neurodegenerative
      disorders such as Alzheimer`s disease are a growing public-health concern with devastating
      effects.

      Referring to animal data, empirical studies, and pilot human trials, dietary modification
      (caloric restriction, omega-3 fatty acids and resveratrol) should improve cognitive functions
      such as learning and memory. To test this hypothesis, the researchers study general brain
      functions in elderly subjects (50-80 years old) with mild cognitive impairment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alzheimer's Disease Assessment Scale - cognitive subscale</measure>
    <time_frame>Prior to intervention and after 6 months of intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional/Structural brain changes</measure>
    <time_frame>Prior to intervention and after 6 months of intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma biomarkers</measure>
    <time_frame>Prior to intervention and after 6 months of intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Caloric restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>omega-3 supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>resveratrol supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd step: intervention + physical /cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>most effective dietary intervention plus physical and cognitive training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd step: most effective dietary intervention plus control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>most effective dietary intervention plus control</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>caloric restriction</intervention_name>
    <description>6 months of caloric restriction (15 %)</description>
    <arm_group_label>Caloric restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>omega-3 supplementation</intervention_name>
    <description>6 months of omega-3 supplementation</description>
    <arm_group_label>omega-3 supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>resveratrol supplementation</intervention_name>
    <description>6 months of resveratrol supplementation</description>
    <arm_group_label>resveratrol supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>6 months of placebo intake</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>2nd step: intervention + physical / cognitive training</intervention_name>
    <description>most effective dietary intervention plus physical and cognitive training</description>
    <arm_group_label>2nd step: intervention + physical /cognitive training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>2nd step: intervention + control</intervention_name>
    <description>most effective dietary intervention plus control</description>
    <arm_group_label>2nd step: most effective dietary intervention plus control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects with mild cognitive impairment

          -  50-80 years old

          -  moderate to heavy weight (BMI 25-35)

        Exclusion Criteria:

          -  dementia

          -  diabetes

          -  severe disease

          -  younger than 50 years

          -  BMI &lt; 25
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Floeel, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Charité University Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 2016 May 1;131:226-38. doi: 10.1016/j.neuroimage.2015.09.050. Epub 2015 Oct 1.</citation>
    <PMID>26433119</PMID>
  </results_reference>
  <results_reference>
    <citation>Köbe T, Witte AV, Schnelle A, Tesky VA, Pantel J, Schuchardt JP, Hahn A, Bohlken J, Grittner U, Flöel A. Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment. Front Neurosci. 2017 Mar 7;11:105. doi: 10.3389/fnins.2017.00105. eCollection 2017.</citation>
    <PMID>28326010</PMID>
  </results_reference>
  <results_reference>
    <citation>Witte AV, Köbe T, Graunke A, Schuchardt JP, Hahn A, Tesky VA, Pantel J, Flöel A. Impact of leptin on memory function and hippocampal structure in mild cognitive impairment. Hum Brain Mapp. 2016 Dec;37(12):4539-4549. doi: 10.1002/hbm.23327. Epub 2016 Aug 11.</citation>
    <PMID>27511061</PMID>
  </results_reference>
  <results_reference>
    <citation>Wirth M, Pichet Binette A, Brunecker P, Köbe T, Witte AV, Flöel A. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. J Cereb Blood Flow Metab. 2017 Mar;37(3):814-824. doi: 10.1177/0271678X16641128. Epub 2016 Jul 20.</citation>
    <PMID>27037094</PMID>
  </results_reference>
  <results_reference>
    <citation>Köbe T, Witte AV, Schnelle A, Grittner U, Tesky VA, Pantel J, Schuchardt JP, Hahn A, Bohlken J, Rujescu D, Flöel A. Vitamin B-12 concentration, memory performance, and hippocampal structure in patients with mild cognitive impairment. Am J Clin Nutr. 2016 Apr;103(4):1045-54. doi: 10.3945/ajcn.115.116970. Epub 2016 Feb 24.</citation>
    <PMID>26912492</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2010</study_first_submitted>
  <study_first_submitted_qc>October 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2010</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Agnes Flöel</investigator_full_name>
    <investigator_title>Prof. Dr. med. Agnes Flöel, Neurologie</investigator_title>
  </responsible_party>
  <keyword>memory</keyword>
  <keyword>diet</keyword>
  <keyword>elderly</keyword>
  <keyword>cognition</keyword>
  <keyword>prevention</keyword>
  <keyword>lifestyle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Resveratrol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

